WestEnd Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Other funds holding TMO
WestEnd Advisors's TMO Position: Q3 2026 in Review
WestEnd Advisors increased its Thermo Fisher Scientific (TMO) stake by 5.3% in Q3 2026, buying an estimated $2.23M and bringing the position to 74,543 shares worth $50.3M. The position accounts for 1.11% of the portfolio, ranked #22.
WestEnd Advisors first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $50.8M in Q4 2025. 2,801 funds tracked by Wall St. Rank hold TMO as of Q3 2026.
- WestEnd Advisors held 74,543 shares of Thermo Fisher Scientific worth $50.3M as of Q3 2026.
- WestEnd Advisors bought 3,759 Thermo Fisher Scientific shares in Q3 2026, an estimated $2.23M.
- Thermo Fisher Scientific made up 1.11% of WestEnd Advisors's portfolio in Q3 2026, its #22 holding.
- WestEnd Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
- WestEnd Advisors's Thermo Fisher Scientific position peaked at $50.8M in Q4 2025.
- 2,801 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.
Based on WestEnd Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.